Balyasny Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-993,429
Closed -$98.6M 1648
2019
Q3
$98.6M Buy
993,429
+377,766
+61% +$35.9M 0.68% 16
2019
Q2
$56.9M Buy
615,663
+345,663
+128% +$32.8M 0.36% 53
2019
Q1
$25.5M Sell
270,000
-56,627
-17% -$4.95M 0.17% 178
2018
Q4
$20.9M Buy
326,627
+306,787
+1,546% +$22.6M 0.15% 191
2018
Q3
$1.77M Buy
19,840
+1,175
+6% +$104K 0.01% 1023
2018
Q2
$1.48M Sell
18,665
-419,474
-96% -$34.8M 0.01% 1029
2018
Q1
$39.1M Buy
438,139
+218,848
+100% +$21M 0.16% 173
2017
Q4
$22.9M Sell
219,291
-87,120
-28% -$9.83M 0.07% 360
2017
Q3
$44.7M Sell
306,411
-81,105
-21% -$11M 0.18% 156
2017
Q2
$50.3M Buy
387,516
+158,092
+69% +$19.4M 0.21% 124
2017
Q1
$28.5M Sell
229,424
-615,630
-73% -$73.7M 0.13% 199
2016
Q4
$97.8M Buy
845,054
+485,317
+135% +$54M 0.53% 22
2016
Q3
$37.6M Buy
359,737
+31,806
+10% +$3.44M 0.22% 145
2016
Q2
$32.3M Buy
327,931
+316,667
+2,811% +$32.8M 0.21% 129
2016
Q1
$1.13M Buy
11,264
+8,028
+248% +$827K 0.01% 755
2015
Q4
$388K Sell
3,236
-104,842
-97% -$12.1M ﹤0.01% 898
2015
Q3
$11.7M Buy
108,078
+48,228
+81% +$5.98M 0.09% 304
2015
Q2
$6.93M Buy
+59,850
New +$6.84M 0.04% 502
2013
Q3
Sell
-127,680
Closed -$7.47M 834
2013
Q2
$7.47M Buy
+127,680
New +$7.68M 0.13% 199

Other funds holding CELG

Balyasny Asset Management's CELG Position: Q4 2019 in Review

Balyasny Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 993,429 shares — an estimated $98.6M sold.

Balyasny Asset Management first reported a position in CELG in Q2 2013 and held it in 19 quarters. The position peaked at $98.6M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Balyasny Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Balyasny Asset Management sold 993,429 Celgene Corp shares in Q4 2019, an estimated $98.6M.
  • Balyasny Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 19 quarters.
  • Balyasny Asset Management's Celgene Corp position peaked at $98.6M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Balyasny Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.